The natural history of epilepsy in tuberous sclerosis complex

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Epilepsia

• Publication date

  2009-12-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1528-1167.2009.02474.xPMID 20041940PMCID PMC3065368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex.

  2008cited by this paper
• Cognitive impairment in tuberous sclerosis complex is a multifactorial condition

  2008cited by this paper
• Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations

  2008influential reference
• Epilepsy Surgery in Tuberous Sclerosis: A Systematic Review

  2007cited by this paper
• Cognitive prognosis of patients with tuberous sclerosis complex

  2007cited by this paper
• Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challenges

  2007cited by this paper
• The tuberous sclerosis complex.

  2006cited by this paper
• Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland

  2006cited by this paper
• How long does it take for epilepsy to become intractable? A prospective investigation

  2006cited by this paper
• mTOR and cancer: insights into a complex relationship

  2006cited by this paper
• Neurocutaneous Syndromes and Epilepsy—Issues in Diagnosis and Management

  2005cited by this paper
• Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex

  2005cited by this paper
• Tuberous Sclerosis Complex and the Ketogenic Diet

  2005cited by this paper
• Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

  2005cited by this paper
• Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

  2005cited by this paper
• Growing roles for the mTOR pathway.

  2005cited by this paper
• Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex

  2005cited by this paper
• The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex

  2004cited by this paper
• Managing Epilepsy in Tuberous Sclerosis Complex

  2004cited by this paper
• Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex

  2004cited by this paper
• Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex.

  2003cited by this paper
• Infantile spasms in tuberous sclerosis complex.

  2001cited by this paper
• Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

  2001cited by this paper
• Tuberous sclerosis complex: Developmental perspectives in psychiatry

  2000cited by this paper
• Usefulness of Diagnostic Criteria of Tuberous Sclerosis Complex in Pediatric Patients

  2000influential reference
• Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic Criteria

  1998cited by this paper
• MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDY

  1996influential reference
• Tuberous sclerosis.

  1995cited by this paper
• Tuberous sclerosis.

  1994cited by this paper
• Causes of death in patients with tuberous sclerosis.

  1991cited by this paper
• On the incidence of fits and mental retardation in tuberous sclerosis.

  1991cited by this paper
• The tuberous sclerosis syndrome: clinical and EEG studies in 100 children.

  1976cited by this paper

• Merritt-Putnam Symposium | Tumor-Associated Epilepsy and Epilepsy-Associated Tumors: Exploring the Bidirectional Crosstalk Between Tumors and Seizures.

  2026cites this paper
• Parameter-efficient convolutional neural network for drug treatment outcome studies of pediatric epilepsy.

  2026cites this paper
• Anti-seizure potential of J4, an equilibrative nucleoside transporter 1 inhibitor, in a mouse model of tuberous sclerosis complex in response to pentylenetetrazol

  2026cites this paper
• Intellectual disability and autistic behavior and their modifying factors in children with tuberous sclerosis complex.

  2025cites this paper
• Neurodevelopmental Outcomes From the PREVeNT Trial.

  2025cites this paper
• Behavioral analyses in rodent models of tuberous sclerosis complex.

  2025cites this paper
• Cerebral Organoids Uncover Mechanisms of Neural Activity Changes in Epileptogenesis

  2025cites this paper
• Brain Tumor Related Epilepsy: Pathophysiology and Multimodal Approach to Management

  2025cites this paper
• Tuberous Sclerosis Complex: An updated in the treatment of epilepsy for early careers.

  2025cites this paper
• Cortical Tuber Types in Tuberous Sclerosis Complex: Need for New MRI-Based Classification System Incorporating Changes in Susceptibility Weighted Imaging

  2025cites this paper
• Epilepsy surgery in infants and young children with tuberous sclerosis.

  2025cites this paper
• Comparative Study on Modulation of Synchronized Neuronal Activity by SK Channels and Na/K-ATPase

  2025cites this paper
• Insights into Tuberous Sclerosis Complex : From Genes to Clinics

  2025influential citation
• An overview of the value of mTOR inhibitors to the treatment of epilepsy: the evidence to date

  2025cites this paper
• Infantile Spasms (West Syndrome): Integrating Genetic, Neurotrophic, and Hormonal Mechanisms Toward Precision Therapy

  2025cites this paper
• Clinical outcomes following stereotactic MRI-guided laser ablation in children with tuberous sclerosis complex and intractable epilepsy.

  2025cites this paper
• Genetic screening of tuberous sclerosis complex in Sicily with a focus on neurological manifestations

  2025cites this paper
• Diagnostic accuracy of T2-hypointensity in determining the epileptogenic lesion on unmyelinated brain MRI in infants with tuberous sclerosis complex (TSC)

  2025cites this paper
• Neuropsychiatric profile in tuberous sclerosis complex patients with epilepsy

  2025cites this paper
• Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy

  2025cites this paper
• Tuberous Sclerosis Complex: New Insights into Pathogenesis and Therapeutic Breakthroughs

  2025cites this paper
• Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study

  2025cites this paper
• Cardiac rhabdomyomas in tuberous sclerosis complex: clinical manifestations and genotype correlations

  2025cites this paper
• Mortality in Tuberous sclerosis Complex: Current understandings.

  2025cites this paper
• Epilepsy Surgery in Tuberous Sclerosis Complex: A TSC Natural History Database Study.

  2025cites this paper
• Relationship between cortical tuber subtypes and interictal epileptiform discharges in tuberous sclerosis complex: MRI and scalp-EEG study.

  2025cites this paper
• Burden of illness in tuberous sclerosis complex-associated epilepsy: a systematic literature review of epidemiology, health-related quality of life, costs and resource use

  2025cites this paper
• Treatment of Seizures in People with Intellectual Disability

  2025influential citation
• Developmental Outcome at 36 Months in Tuberous Sclerosis: Are There any Modifiable Predictors?

  2025cites this paper
• Case Report: A patient with cardiac rhabdomyoma associated with embryonal developmental dysplasia of neuroepithelial tumors, presenting with recurrent cyanosis of the face and lips

  2025cites this paper
• Tuberoskleroz Tanısı ile İzlenen Hastaların Klinik Özellikleri: Tek Merkez Deneyimi

  2025cites this paper
• Lesions Associated With Autism Symptoms Map to a Cerebellar Brain Network in Tuberous Sclerosis Complex

  2025cites this paper
• Congenital Localized Hypopigmentation Disorders as a Clue of Severe Neurologic Involvement: An Update Review

  2025cites this paper
• Tuberous sclerosis complex: Clinical, genetic and 7T-MRI neuroimaging findings.

  2025cites this paper
• Trifluoperazine, an Antipsychotic Drug, Inhibits Viability of Cells Derived From SEGA and Cortical Tubers Cultured In Vitro

  2025cites this paper
• Cognitive and neuro-psychiatric profile in adult patients with epilepsy secondary to Tuberous Sclerosis Complex.

  2025cites this paper
• Neurocutaneous features of tuberous sclerosis complex: A case report from Bangladesh

  2025cites this paper
• Epilepsy surgery outcomes in children with tuberous sclerosis complex: a systematic review and meta-analysis.

  2025cites this paper
• Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome

  2025cites this paper
• Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program

  2024cites this paper
• The role of the TSC Alliance in advancing therapy development: a patient organization perspective

  2024cites this paper
• The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan.

  2024cites this paper
• Have epilepsy outcomes changed for children with tuberous sclerosis complex in Queensland, Australia?

  2024cites this paper
• Diagnostic Features of Tuberous Sclerosis Complex: Case Report and Literature Review

  2024cites this paper
• Genotypic and phenotypic analysis of Korean patients with tuberous sclerosis complex

  2024cites this paper
• A case of tuberous sclerosis complex revealed by epilepsy

  2024cites this paper
• Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.

  2024cites this paper
• Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome

  2024cites this paper
• Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array

  2024cites this paper
• Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results

  2024cites this paper
• A multicenter, matched case–control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany

  2024cites this paper
• Genetic Diagnostic Yield in Autism Spectrum Disorder (ASD) and Epilepsy Phenotypes in Children with Genetically Defined ASD

  2024cites this paper
• A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales

  2024cites this paper
• Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy.

  2024cites this paper
• Seizure freedom but not epilepsy surgery is associated with fewer neuropsychiatric difficulties in patients with tuberous sclerosis.

  2024influential citation
• Patients’ and physicians’ awareness of clinical symptoms and disease severity in tuberous sclerosis complex

  2024cites this paper
• Association of earlier surgery with improved postoperative language development in children with tuberous sclerosis complex.

  2024cites this paper
• Autism and Epilepsy.

  2024cites this paper
• Common epilepsy variants from the general population are not associated with epilepsy among individuals with tuberous sclerosis complex

  2024cites this paper
• EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy

  2024cites this paper
• Treatment guidelines for rare, early-onset conditions associated with epileptic seizures: a literature review on Rett syndrome and tuberous sclerosis complex

  2024cites this paper
• Deep Learning Approaches for Imaging-Based Automated Segmentation of Tuberous Sclerosis Complex

  2024cites this paper
• Stereoelectroencephalography and surgical treatment of TSC-associated epilepsy in children: preliminary results

  2024cites this paper
• Diagnostic flow analysis of tuberous sclerosis complex in Japan: a retrospective claims database study

  2024cites this paper
• Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous sclerosis complex

  2024cites this paper
• Cenobamate's Efficacy for Seizure Treatment in Tuberous Sclerosis Complex.

  2024cites this paper
• Calvarial thickening in tuberous sclerosis complex.

  2024cites this paper
• Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm.

  2024cites this paper
• Atypical case of tuberous sclerosis with isolated neurologic findings: A case report

  2024cites this paper
• Tuberous sclerosis complex: a case report

  2024cites this paper
• NS-Pten knockout mice exhibit sex and hippocampal subregion-specific increases in microglia/macrophage density.

  2024cites this paper
• Epilepsy surgery for tuberous sclerosis complex in children: literature review and clinical case

  2024cites this paper
• Tuberous sclerosis complex: Diagnostic features, surveillance, and therapeutic strategies.

  2024cites this paper
• Tuberous sclerosis complex in adulthood: focus on epilepsy prognosis.

  2024cites this paper
• Somatostatin-expressing inhibitory neurons with mTORC1 activation in cortical layers 4/5 are involved in the epileptogenesis of mice

  2024cites this paper
• Vigabatrin‐associated brain magnetic resonance imaging abnormalities and clinical symptoms in infants with tuberous sclerosis complex

  2024cites this paper
• Tsc1 Loss in VIP-Lineage Cortical Interneurons Results in More VIP+ Interneurons and Enhanced Excitability

  2023cites this paper
• The Evolving Landscape of Therapeutics for Epilepsy in Tuberous Sclerosis Complex

  2023cites this paper
• Predicting Antiseizure Medication Treatment in Children with Rare Tuberous Sclerosis Complex–Related Epilepsy Using Deep Learning

  2023cites this paper
• Retrospective Analysis of Canadian Adults with Tuberous Sclerosis Complex

  2023cites this paper
• Treatment of tuberous sclerosis complex manifestations in children with mTOR inhibitors

  2023cites this paper
• The profile of epilepsy and its characteristics in children with neurocutaneous syndromes

  2023cites this paper
• Activated protein C in epilepsy pathophysiology

  2023cites this paper
• Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?

  2023cites this paper
• Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice

  2023cites this paper
• A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex

  2023influential citation
• Responsive Neurostimulation for the Treatment of Children With Drug-Resistant Epilepsy in Tuberous Sclerosis Complex.

  2023cites this paper
• Paradigm shift in the treatment of tuberous sclerosis: effectiveness of everolimus.

  2023cites this paper
• Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial

  2023cites this paper
• Recognizing Pediatric Tuberous Sclerosis Complex Based on Multi-Contrast MRI and Deep Weighted Fusion Network

  2023cites this paper
• Wait and see en epilepsia pediátrica. Nuestra experiencia

  2023cites this paper
• 3D-EEG Source Imaging Moving Dipole Methodology Reduces Surgical Failure In Pediatric Patients With Tuberous Sclerosis Complex

  2023cites this paper
• Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy.

  2023cites this paper
• Predicting Drug Treatment Outcomes in Childrens with Tuberous Sclerosis Complex–Related Epilepsy: A Clinical Radiomics Study

  2023cites this paper
• Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age

  2023cites this paper
• Childhood tuberous sclerosis complex in southern Sweden: a paradigm shift in diagnosis and treatment

  2023cites this paper
• Epilepsy Severity Is Associated With Head Circumference and Growth Rate in Infants With Tuberous Sclerosis Complex.

  2023cites this paper
• Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions

  2023cites this paper
• Rapamycin and rapalogs for tuberous sclerosis complex.

  2023cites this paper
• Polymicrogyria: epidemiology, imaging, and clinical aspects in a population-based cohort

  2023cites this paper